Partners
The technology behind new therapies ›
The opportunity
One platform, broad downstream value ›
Alvion Bio sits at the start of the cell-therapy value chain. We supply 
, a proprietary neonatal MSC platform, to the developers, clinicians and researchers who turn cells into cures. It is a single foundation with optionality across many downstream programmes, and a position that is defensible by source, method and scale.
Where we sit
Upstream, where quality is decided ›
The further upstream the supplier, the more programmes depend on it. Alvion Bio is the cell source beneath the therapies.
We make and supply Revalyxis neonatal MSCs: the qualified starting material the entire chain depends on. This is where quality is decided.
Investment highlights
Why Alvion Bio ›
Defensible source
An ethically obtained, proprietary amniotic source. The combination of source, method and scale is hard for competitors to replicate.
Upstream position
A supplier at the foundation of the value chain, where many downstream programmes converge on one dependable source.
Quality at scale
A platform built so quality and consistency hold as volume grows, rather than degrading.
Singular focus
We make the cells and nothing else, so we make them exceptionally well.
Optionality
One platform with application across multiple downstream therapeutic and research programmes.
Enabling partner
We carry the cell-supply risk so partners can focus on the cure, making us central to their success.
Roadmap
Building the platform, in stages ›
A staged path from a proven neonatal platform to high-quality supply at scale. Detailed milestones are shared under confidentiality.
Foundation
Proprietary platform established
Amniotic fluid stem cell platform, , characterised and protected.
Process
Isolation & expansion defined
Repeatable isolation, characterisation and expansion to a documented standard.
Scale
Supply at scale
Banking and release at the quality and volume partner programmes require.
Growth
Partner programmes at scale
Multiple downstream developers supplied from one dependable source.
What partnership looks like
A focused supplier, behind your programme ›
We carry the cell-supply risk
Alvion Bio does one thing: make the cells. That focus lets partners build on a dependable foundation rather than managing an upstream source themselves.
Provenance you can stand behind
Characterisation and chain-of-custody documentation accompany every supply, giving partners and their review boards a clear, defensible basis.
Materials
Request the information pack ›
Partner enquiries
Materials are shared on request, under confidentiality where appropriate. Contact Justin.Pierce@alvionbio.com.
This page is informational and not an offer of securities. Statements are factual and avoid forward-looking promises; figures are confirmed in materials shared directly. Please have partner communications reviewed before publishing.